We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-5.66%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$449B
AUM Growth
-$36.8B
Cap. Flow
-$692M
Cap. Flow %
-0.15%
Top 10 Hldgs %
15.79%
Holding
2,618
New
86
Increased
1,108
Reduced
800
Closed
108

Top Sells

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$1.76B
2
BIIB icon
Biogen
BIIB
+$1.47B
3
PCP
PRECISION CASTPARTS CORP
PCP
+$1.26B
4
MCK icon
McKesson
MCK
+$1.2B
5
SHW icon
Sherwin-Williams
SHW
+$1.12B

Sector Composition

Rank Sector Weight
1 Healthcare 21.75%
2 Consumer Discretionary 14.84%
3 Financials 13.9%
4 Technology 11.11%
5 Industrials 9.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBOC icon
1976
International Bancshares
IBOC
$4.55B
$463K ﹤0.01%
18,514
INDB icon
1977
Independent Bank
INDB
$4.06B
$463K ﹤0.01%
10,050
ACH
1978
Accendra Health
ACH
$84.6M
$463K ﹤0.01%
14,500
MDC
1979
DELISTED
M.D.C. Holdings, Inc.
MDC
$462K ﹤0.01%
24,512
+3,861
+19% +$80.8K
CNMD icon
1980
CONMED
CNMD
$1.48B
$461K ﹤0.01%
9,650
LZB icon
1981
La-Z-Boy
LZB
$1.67B
$461K ﹤0.01%
17,350
PAG icon
1982
Penske Automotive Group
PAG
$14.3B
$461K ﹤0.01%
9,516
+2,100
+28% +$108K
TRI icon
1983
Thomson Reuters
TRI
$44.5B
$460K ﹤0.01%
9,910
+518
+6% +$23.6K
FCNCA icon
1984
First Citizens BancShares
FCNCA
$25.7B
$459K ﹤0.01%
2,030
WERN icon
1985
Werner Enterprises
WERN
$2.31B
$458K ﹤0.01%
18,262
NHI icon
1986
National Health Investors
NHI
$3.52B
$454K ﹤0.01%
7,890
PLXS icon
1987
Plexus
PLXS
$7.22B
$454K ﹤0.01%
11,760
ZNGA
1988
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$454K ﹤0.01%
199,316
+49,300
+33% +$126K
MACK
1989
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$454K ﹤0.01%
6,787
+1,284
+23% +$105K
WMC
1990
DELISTED
Western Asset Mortgage Capital Corporation
WMC
$450K ﹤0.01%
3,572
+580
+19% +$79.2K
PMT
1991
PennyMac Mortgage Investment
PMT
$836M
$449K ﹤0.01%
29,000
HT
1992
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$449K ﹤0.01%
19,800
RGC
1993
DELISTED
Regal Entertainment Group
RGC
$448K ﹤0.01%
23,990
MMSI icon
1994
Merit Medical Systems
MMSI
$5.42B
$447K ﹤0.01%
18,706
+3,600
+24% +$84.7K
BAH icon
1995
Booz Allen Hamilton
BAH
$9.36B
$443K ﹤0.01%
16,900
SSB icon
1996
SouthState Bank Corp
SSB
$10.8B
$443K ﹤0.01%
5,759
WGO icon
1997
Winnebago Industries
WGO
$922M
$443K ﹤0.01%
23,120
+7,700
+50% +$163K
LKFN icon
1998
Lakeland Financial Corp
LKFN
$1.56B
$442K ﹤0.01%
14,700
TIVO
1999
DELISTED
TIVO INC
TIVO
$436K ﹤0.01%
50,300
+7,600
+18% +$72.1K
DOC
2000
DELISTED
PHYSICIANS REALTY TRUST
DOC
$435K ﹤0.01%
28,800

Similar funds

T. Rowe Price Associates's Q3 2015 Portfolio in Review

As of Q3 2015, T. Rowe Price Associates held 2,618 positions worth $449B, down 7.6% from $486B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

T. Rowe Price Associates's Q3 2015 filing shows 86 new, 1,108 increased, 800 reduced and 108 closed positions. Its largest new stake was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M. The largest sale was Baidu, an estimated $1.76B.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q3 2015 buy was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M.
  • T. Rowe Price Associates added most to Microsoft in Q3 2015, an estimated $1.57B increase.
  • T. Rowe Price Associates's biggest Q3 2015 reduction was Baidu, cutting an estimated $1.76B.
  • T. Rowe Price Associates fully exited HOSPIRA INC in Q3 2015, selling an estimated $988M.
  • T. Rowe Price Associates's ten largest holdings make up 16% of its $449B portfolio in Q3 2015.
  • T. Rowe Price Associates opened 86 new positions and closed 108 in Q3 2015.
  • T. Rowe Price Associates's portfolio value fell 7.6% quarter-over-quarter to $449B.

Based on T. Rowe Price Associates's 13F filing for Q3 2015, filed 13 Nov 2015.